These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 11522469

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.
    Cussac D, Duqueyroix D, Newman-Tancredi A, Millan MJ.
    Psychopharmacology (Berl); 2002 Jul; 162(2):168-77. PubMed ID: 12110994
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.
    Newman-Tancredi A, Gavaudan S, Conte C, Chaput C, Touzard M, Verrièle L, Audinot V, Millan MJ.
    Eur J Pharmacol; 1998 Aug 21; 355(2-3):245-56. PubMed ID: 9760039
    [Abstract] [Full Text] [Related]

  • 6. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G.
    J Pharmacol Exp Ther; 1998 Sep 21; 286(3):1341-55. PubMed ID: 9732398
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inverse agonists and serotonergic transmission: from recombinant, human serotonin (5-HT)1B receptors to G-protein coupling and function in corticolimbic structures in vivo.
    Millan MJ, Gobert A, Audinot V, Dekeyne A, Newman-Tancredi A.
    Neuropsychopharmacology; 1999 Aug 21; 21(2 Suppl):61S-67S. PubMed ID: 10432490
    [Abstract] [Full Text] [Related]

  • 9. Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors.
    Newman-Tancredi A, Cussac D, Audinot V, Millan MJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun 21; 359(6):447-53. PubMed ID: 10431754
    [Abstract] [Full Text] [Related]

  • 10. Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells.
    Heusler P, Newman-Tancredi A, Loock T, Cussac D.
    Eur J Pharmacol; 2008 Feb 26; 581(1-2):37-46. PubMed ID: 18190908
    [Abstract] [Full Text] [Related]

  • 11. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
    Newman-Tancredi A, Verrièle L, Millan MJ.
    Br J Pharmacol; 2001 Jan 26; 132(2):518-24. PubMed ID: 11159702
    [Abstract] [Full Text] [Related]

  • 12. Constitutive activity at serotonin 5-HT(1D) receptors: detection by homologous GTPgammaS versus [(35)S]-GTPgammaS binding isotherms.
    Audinot V, Newman-Tancredi A, Millan MJ.
    Neuropharmacology; 2001 Jan 26; 40(1):57-64. PubMed ID: 11077071
    [Abstract] [Full Text] [Related]

  • 13. h5-HT(1B) receptor-mediated constitutive Galphai3-protein activation in stably transfected Chinese hamster ovary cells: an antibody capture assay reveals protean efficacy of 5-HT.
    Newman-Tancredi A, Cussac D, Marini L, Touzard M, Millan MJ.
    Br J Pharmacol; 2003 Mar 26; 138(6):1077-84. PubMed ID: 12684263
    [Abstract] [Full Text] [Related]

  • 14. Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924.
    Newman-Tancredi A, Rivet JM, Cussac D, Touzard M, Chaput C, Marini L, Millan MJ.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Sep 26; 368(3):188-99. PubMed ID: 12923612
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation.
    Newman-Tancredi A, Verrièle L, Touzard M, Millan MJ.
    Eur J Pharmacol; 2001 Oct 05; 428(2):177-84. PubMed ID: 11675034
    [Abstract] [Full Text] [Related]

  • 16. Reconstitution of the human 5-HT(1D) receptor-G-protein coupling: evidence for constitutive activity and multiple receptor conformations.
    Brys R, Josson K, Castelli MP, Jurzak M, Lijnen P, Gommeren W, Leysen JE.
    Mol Pharmacol; 2000 Jun 05; 57(6):1132-41. PubMed ID: 10825383
    [Abstract] [Full Text] [Related]

  • 17. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul 05; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 18. Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT(1B) receptor/G-protein stoichiometry.
    Newman-Tancredi A, Audinot V, Moreira C, Verrièle L, Millan MJ.
    Mol Pharmacol; 2000 Nov 05; 58(5):1042-9. PubMed ID: 11040052
    [Abstract] [Full Text] [Related]

  • 19. Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties.
    Rauly-Lestienne I, Boutet-Robinet E, Ailhaud MC, Newman-Tancredi A, Cussac D.
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Oct 05; 376(1-2):93-105. PubMed ID: 17786406
    [Abstract] [Full Text] [Related]

  • 20. 3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonists.
    Russell MG, Matassa VG, Pengilley RR, van Niel MB, Sohal B, Watt AP, Hitzel L, Beer MS, Stanton JA, Broughton HB, Castro JL.
    J Med Chem; 1999 Dec 02; 42(24):4981-5001. PubMed ID: 10585208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.